首页> 外文OA文献 >Molecular identification of the vaccine strain from the inactivated oil emulsion H9N2 low pathogenic avian influenza vaccine
【2h】

Molecular identification of the vaccine strain from the inactivated oil emulsion H9N2 low pathogenic avian influenza vaccine

机译:从灭活的油乳剂H9N2低致病性禽流感疫苗中鉴定疫苗株的分子

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In order to control the H9N2 subtype low pathogenic avian influenza (LPAI), an inactivated vaccine has been used in Korea since 2007. The Korean veterinary authority permitted the use of a single H9N2 LPAI vaccine strain to simplify the evolution of the circulating virus due to the immune pressure caused by the vaccine use. It is therefore important to determine the suitability of the vaccine strain in the final inactivated oil emulsion LPAI vaccine. In this study, we applied molecular rather than biological methods to verify the suitability of the vaccine strain used in commercial vaccines and successfully identified the strain by comparing the nucleotide sequences of the hemagglutinin and neuraminidase genes with that of the permitted Korean LPAI vaccine strain. It is thought that the method used in this study might be successfully applied to other viral genes of the LPAI vaccine strain and perhaps to other veterinary oil emulsion vaccines.
机译:为了控制H9N2亚型低致病性禽流感(LPAI),韩国已于2007年开始使用灭活疫苗。韩国兽医机构允许使用一种H9N2 LPAI疫苗株,以简化由于疫苗使用引起的免疫压力。因此,重要的是确定疫苗菌株在最终灭活的油乳剂LPAI疫苗中的适用性。在这项研究中,我们应用分子方法而非生物学方法来验证用于商业疫苗的疫苗株的适用性,并通过比较血凝素和神经氨酸酶基因的核苷酸序列与获准的韩国LPAI疫苗株的核苷酸序列,成功鉴定出该菌株。认为该研究中使用的方法可能成功地应用于LPAI疫苗株的其他病毒基因,也许还可以应用于其他兽用油乳剂疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号